Dykan Jeff's Form 4/A amendment
AmendedLifeward Ltd. (LFWD) · filed Jun 30, 2022
- Accession no.
- 0001062993-22-015670
- Filed
- Jun 30, 2022
- Trade date
- Jun 7-8, 2022
- Filing delay
- 23 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jun 9, 2022
This filing lists 2 non-derivative transactions. Open-market purchases total $25.4K. It was filed 23 days after the trade.
This amendment replaces 0001062993-22-014549 (filed Jun 9, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dykan JeffCIK 0001661229 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2022 | Ordinary Shares, par value NIS 0.25 per share | PPurchaseAcquired | +15,000 | $1.00F3 | +$15,000 | 32,162 | Direct | |
| Jun 8, 2022 | Ordinary Shares, par value NIS 0.25 per share | PPurchaseAcquired | +10,000 | $1.04F5 | +$10,400 | 42,162 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This amendment is being filed to correct the number of shares directly and indirectly held by the reporting person. On July 7, 2020, the reporting person reported the acquisition of 10,948 Ordinary Shares underlying restricted stock units, which were granted to the reporting person on July 2, 2020 pursuant to the issuer's equity compensation plan. Such Ordinary Shares should have been reported as directly held, but due to an administrative error, such shares were mistakenly reported as indirectly held. See also footnote 6.
- F2
Represents Ordinary Shares purchased in the open market on June 7, 2022.
- F3
The range in prices for the transaction reported on this line was $1.00 to $1.01. The average weighted price was $1.00. The reporting person will provide, upon request by the Securities and Exchange Commission ("SEC"), the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within such range.
Referenced by the price of 1 transaction in Table I.
- F4
Represents Ordinary Shares purchased in the open market on June 8, 2022.
- F5
The range in prices for the transaction reported on this line was $1.03 to $1.04. The average weighted price was $1.04. The reporting person will provide, upon request by the SEC, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within such range.
Referenced by the price of 1 transaction in Table I.
- F6
Based on filings made with the SEC, consists of 40,707 Ordinary Shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 Ordinary Shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 55,874 shares of the Company.